Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Otonomy, Inc.
Age
18–85
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Subject has a diagnosis of unilateral Meniere's disease by 1995 American Academy of Otolaryngology - Head and Neck Surgery (AAOHNS) criteria and reports active vertigo for the 2 months prior to the study lead-in period.
Subject has experienced active vertigo during the lead-in period.
Subject has documented asymmetric sensorineural hearing loss.
Subject agrees to maintain their current treatments for Meniere's disease while on-study.
You may not be if
Subject is pregnant or lactating.
Subject has a history of immunodeficiency disease.
Subject has a history of significant middle ear or inner ear surgery, or endolymphatic sac surgery in the affected ear.
Subject has a history of tympanostomy tubes with evidence of perforation or lack of closure.
Subject has a history of vestibular migraine.
Subject has used an investigational drug or device in the 3 months prior to screening.
Subject has previously been randomized to a clinical study of OTO-104.
Clareo Health | Phase 3 Study of OTO-104 in Subjects With Unilateral Meniere's Disease
